162 related articles for article (PubMed ID: 31471707)
1. CT and MR imaging findings of the livers in adults with Fontan palliation: an observational study.
Yang HK; Jang HJ; Khalili K; Wald RM; Yoo SJ; Kim TK
Abdom Radiol (NY); 2020 Jan; 45(1):188-202. PubMed ID: 31471707
[TBL] [Abstract][Full Text] [Related]
2. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
3. Hepatic pathology after Fontan palliation: spectrum of imaging findings.
Wallihan DB; Podberesky DJ
Pediatr Radiol; 2013 Mar; 43(3):330-8. PubMed ID: 23052733
[TBL] [Abstract][Full Text] [Related]
4. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
5. Focal liver lesions following Fontan palliation of single ventricle physiology: A radiology-pathology case series.
Engelhardt EM; Trout AT; Sheridan RM; Veldtman GR; Dillman JR
Congenit Heart Dis; 2019 May; 14(3):380-388. PubMed ID: 30569564
[TBL] [Abstract][Full Text] [Related]
6. Fontan-associated liver disease: Spectrum of US findings.
Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
[TBL] [Abstract][Full Text] [Related]
7. Imaging Assessment of Hepatic Changes after Fontan Surgery.
Song J; Kim K; Huh J; Kang IS; Kim SH; Yang JH; Jun TG; Kim JH
Int Heart J; 2018 Sep; 59(5):1008-1014. PubMed ID: 30158375
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
[TBL] [Abstract][Full Text] [Related]
9. Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI.
Horvat N; Rocha MS; Chagas AL; Oliveira BC; Pacheco MP; Binotto MA; Ikari NM; Paranaguá-Vezozzo DC; Leao-Filho HM; Vicentini JRT; Moreira da Silva Filho MR; Jatene MB; Carrilho FJ; Cerri GG
AJR Am J Roentgenol; 2018 Dec; 211(6):1212-1220. PubMed ID: 30247977
[TBL] [Abstract][Full Text] [Related]
10. Cardiac MRI-Derived Inferior Vena Cava Cross-Sectional Area Correlates with Measures of Fontan-Associated Liver Disease.
Gunsaulus M; Wang L; Haack L; Christopher A; Feingold B; Squires J; Horslen S; Hoskoppal A; Rose-Felker K; West S; Trucco S; Squires J; Olivieri L; Kreutzer J; Goldstein B; Alsaied T
Pediatr Cardiol; 2024 Apr; 45(4):909-920. PubMed ID: 36454265
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
[TBL] [Abstract][Full Text] [Related]
12. MRI measured liver stiffness does not predict focal liver lesions after the Fontan operation.
Diaz ES; Dillman JR; Veldtman GR; Trout AT
Pediatr Radiol; 2019 Jan; 49(1):99-104. PubMed ID: 30269160
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and abdominal flow alterations in adults with morphologic evidence of liver disease post Fontan palliation.
Abbasi Bavil E; Yang HK; Doyle MG; Kim TK; Karur G; Bhagra C; Bhagra S; Oechslin EN; Ross H; Roche SL; Gonzalez RA; Amon CH; Mertens L; Wald RM
Int J Cardiol; 2020 Oct; 317():63-69. PubMed ID: 32470536
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.
Kim BR; Lee JM; Lee DH; Yoon JH; Hur BY; Suh KS; Yi NJ; Lee KB; Han JK
Radiology; 2017 Oct; 285(1):134-146. PubMed ID: 28609205
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
16. Relationship of MR elastography determined liver stiffness with cardiac function after Fontan palliation.
Wallihan DB; Podberesky DJ; Marino BS; Sticka JS; Serai S
J Magn Reson Imaging; 2014 Dec; 40(6):1328-35. PubMed ID: 24408379
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents.
Thrane KJ; Müller LSO; Suther KR; Thomassen KS; Holmström H; Thaulow E; Almaas R; Möller T; de Lange C
Abdom Radiol (NY); 2021 Jul; 46(7):3205-3216. PubMed ID: 33688987
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative characterization of dynamic magnetic resonance perfusion of the liver in pediatric Fontan patients.
Navallas M; Yoo SJ; Chavhan GB; Amirabadi A; Ling SC; Seed M; Lam CZ
Pediatr Radiol; 2022 Mar; 52(3):483-492. PubMed ID: 34854967
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
20. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.
Munsterman ID; Duijnhouwer AL; Kendall TJ; Bronkhorst CM; Ronot M; van Wettere M; van Dijk APJ; Drenth JPH; Tjwa ETTL;
Eur Heart J; 2019 Apr; 40(13):1057-1068. PubMed ID: 30346512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
